AN OPEN LABEL PROSPECTIVE STUDY OF THESOLUBLE SERUM MARKER ST2 (IL-33 RECEPTOR) IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS TREATED WITH GOLIMUMAB: CLINICAL, ENDOSCOPIC AND HISTOLOGICAL RESULTS OF THE EVOLUTION STUDY

Fernando Jose Magro Dias  1     Susana Lopes  1     Marco Silva  1     Francisco Portela  2     Diogo Branquinho  2     Luis Correia  3     Samuel Fernandes  4     Marilia Lopes Cravo     Paulo Caldeira     Maria Helena Tavares Sousa     Marta Patita     Isabelle Cremers     Joana Afonso     Isabel Redondo     Patricia Machado     George Philip     Joanne Lopes     Fatima Carneiro    
1 Centro Hospitalar São João,Porto,Portugal
2 Centro Hospitalar Universitário de Coimbra,Coimbra,Portugal
3 Centro Hospitalar Lisboa Norte,Lisboa,Portugal
4 Centro Hospitalar Lisboa Norte,Lisbo

Conference
UEG Week 2018

Citation
United European Gastroenterology Journal 2018; 6 (Supplement 1)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing